5AM Venture Management as of Dec. 31, 2023
Portfolio Holdings for 5AM Venture Management
5AM Venture Management holds 25 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Enliven Therapeutics (ELVN) | 18.9 | $71M | 5.2M | 13.84 | |
Entrada Therapeutics (TRDA) | 17.6 | $67M | 4.4M | 15.09 | |
Pharvaris N V (PHVS) | 5.9 | $22M | 798k | 28.05 | |
Celldex Therapeutics Com New (CLDX) | 5.2 | $20M | 497k | 39.66 | |
Moonlake Immunotherapeutics Class A Ord (MLTX) | 4.8 | $18M | 303k | 60.39 | |
Biohaven (BHVN) | 4.5 | $17M | 400k | 42.80 | |
Disc Medicine (IRON) | 4.5 | $17M | 294k | 57.76 | |
Dianthus Therapeutics (DNTH) | 4.1 | $15M | 1.5M | 10.40 | |
Merus N V (MRUS) | 3.8 | $14M | 522k | 27.50 | |
Vor Biopharma (VOR) | 3.8 | $14M | 6.4M | 2.25 | |
Miragen Therapeutics (VRDN) | 3.4 | $13M | 587k | 21.78 | |
Mirati Therapeutics | 3.0 | $11M | 193k | 58.75 | |
Viking Therapeutics (VKTX) | 2.9 | $11M | 585k | 18.61 | |
Rallybio Corp (RLYB) | 2.3 | $8.7M | 3.6M | 2.39 | |
Tyra Biosciences (TYRA) | 2.0 | $7.7M | 555k | 13.85 | |
Anaptysbio Inc Common (ANAB) | 2.0 | $7.7M | 358k | 21.42 | |
Scpharmaceuticals (SCPH) | 2.0 | $7.5M | 1.2M | 6.27 | |
Zentalis Pharmaceuticals (ZNTL) | 2.0 | $7.4M | 490k | 15.15 | |
Spruce Biosciences (SPRB) | 1.8 | $6.9M | 2.4M | 2.93 | |
Avidity Biosciences Ord (RNA) | 1.6 | $6.0M | 666k | 9.05 | |
Cogent Biosciences (COGT) | 1.2 | $4.6M | 790k | 5.88 | |
Mersana Therapeutics (MRSN) | 0.8 | $3.0M | 1.3M | 2.32 | |
Homology Medicines | 0.7 | $2.8M | 4.5M | 0.61 | |
Gh Research Ordinary Shares (GHRS) | 0.6 | $2.3M | 404k | 5.80 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $901k | 1.1M | 0.79 |